Rosamines targeting the cancer oxidative phosphorylation pathway

Area of Science:

• Mitochondrial biology
• Cancer research
• Pharmacology

Background:

• Cancer cells reprogram energy metabolism, making mitochondria a therapeutic target.
• A previous study identified mitochondria-targeting rosamines with anti-proliferative effects.

Purpose of the Study:

• To evaluate the in vitro cytotoxicity and in vivo efficacy of second-generation rosamine analogs.
• To investigate the mode of action of these novel compounds.

Main Methods:

• In vitro cytotoxicity assays (IC50, GI50) against NCI-60 cell lines.
• Assessment of mitochondrial Complex II and ATP synthase activity.
• Measurement of mitochondrial transmembrane potential.
• In vivo efficacy studies in a 4T1 murine breast cancer model.

Main Results:

• Rosamine analogs demonstrated potent cytotoxicity (average IC50 < 0.5 µM).
• Compounds inhibited mitochondrial oxidative phosphorylation (Complex II, ATP synthase) and reduced mitochondrial membrane potential.
• Analogs 4 and 5 showed significant antiproliferative effects, particularly against colorectal cancer cell lines.
• Preliminary in vivo studies showed minimal tumor growth delay with analog 5.

Conclusions:

• Second-generation rosamine analogs are potent mitochondria-targeting anticancer agents.
• Further development requires strategies to enhance tumor uptake for improved therapeutic outcomes.